Anitocabtagene Autoleucel: RRMM Treatment Results
News Context
At a glance
- Okay, here's a breakdown of the provided text, extracting the citations in a more readable format:
- * The text appears to be HTML code, likely from a webpage.
- If you provide the complete HTML, I can extract the full URL for the third citation.
Okay, here’s a breakdown of the provided text, extracting the citations in a more readable format:
Citations:
- Clinical trial: https://clinicaltrials.gov/study/NCT05396885
- American Cancer Society: CAR T-cell therapy and its side effects. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell.html.Accessed September 23, 2025. (Published July 7, 2025)
- Pharmacy Times: Gerlach A. Anitocabtagene autoleucel yields overall response rate of 97% in patients with multiple myeloma. https://[URL is incomplete in the provided text]. Accessed September 23, 2025. (Published May 14, 2025)
Observations:
* The text appears to be HTML code, likely from a webpage. The <astro-island> tags and associated attributes suggest it’s using the Astro static site generator.
* The citations are formatted as <h6> tags.
* The “ExternalLinkPlugin” seems to be a component used to handle external links, adding rel="noreferrer noopener" target="_self" attributes to the <a> tags.
* The third citation is incomplete; the URL is cut off.
If you provide the complete HTML, I can extract the full URL for the third citation.